Whereas the issue of a certificate for a product consisting of an active substance does not prejudice the issue of other certificates for derivatives (salts and esters) of the substance, provided that the derivatives are the subject of patents specifically covering them;
Recital 14, Regulation (EC) No 1610/96 of the European Parliament and of the Council of 23 July 1996…
Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision
That approach is also borne out by the second subparagraph of paragraph 20 of the explanatory memorandum to the proposal for Council Regulation (EEC) of 11 April 1990 concerning the creation of a supplementary protection certificate for …
24 Nov 2011 · 62010CJ0322
Judgment of the Court (Third Chamber), 12 December 2013. Eli Lilly and Company Ltd v Human Genome Sciences Inc.Decision
The importance of those claims is also borne out by the second subparagraph of paragraph 20 of the Explanatory Memorandum to the Proposal for a Council Regulation (EEC) of 11 April 1990 concerning the creation of a supplementary protection …
12 Dec 2013 · 62012CJ0493
Opinion of Advocate General Saugmandsgaard Øe delivered on 13 December 2018. Abraxis Bioscience LLC v Comptroller General of Patents.Decision
It is, in my opinion, from that perspective that it is necessary to understand recital 14 of Regulation No 1610/96, which Abraxis relies upon in order to establish the validity of the scope of protection of the basic patent test. That …
13 Dec 2018 · 62017CC0443